home / stock / bixt / bixt news

BIXT News and Press, Bioxytran Inc From 04/11/25

Stock Information
Company Name: Bioxytran Inc
Stock Symbol: BIXT
Market: OTC
Website: bioxytraninc.com
Menu
BIXT BIXT Quote BIXT Short BIXT News BIXT Articles BIXT Message Board
Get BIXT Alerts

News, Short Squeeze, Breakout and More Instantly...
BIXT - Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements

- The universal oxygen carrier delivery capabilities of BXT-25 can be monitored, broadening its applications to treat hypoxic diseases - Leading drug candidate ProLectin-M targets galectins in viral infections including bird flu like viruses BOSTON, MASSACHUSETTS, April 11, 2025 (GL...
BIXT - Expected US Company Earnings on Friday, March 28th, 2025

Entera Bio Ltd. (ENTX) is expected to report $-0.08 for Q4 2024 Audacy, Inc. (AUDAQ) is expected to report for quarter end 2024-12-31 The Dixie Group Inc. (DXYN) is expected to report for quarter end 2024-12-31 POET Technologies Inc. (POET) is expected to report $-0.09 for Q4 2024 ...

BIXT - Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens

In Vitro studies have shown promise against viruses similar to the bird flu virus BOSTON, MASSACHUSETTS, March 19, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat vira...

BIXT - Bioxytran Develops a Groundbreaking Treatment to Combat Bird Flu in Egg Laying Chickens Potentially Saving Billions

New water-soluble galectin antagonist being considered in preclinical trials offering hope for rapid containment to H5N1 outbreaks BOSTON, MASSACHUSETTS, March 12, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company de...
BIXT - Investor Ideas New Stocks to Watch in Life Sciences and AI

2025-02-14 09:10:00 ET February 14, 2025 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Life Sciences and AI sectors. The newest life sciences companies are involved in woman's ...

BIXT - Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development

- Repurchasing all convertible note overhang, and - Funding pre-clinical and clinical trials - Management forfeiting $460,000 in accrued payroll BOSTON, MASSACHUSETTS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical s...

BIXT - Bioxytran's Cancer Preprint Reveals Potential to Enhance Most Immunotherapy Drugs

BOSTON, MASSACHUSETTS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its preprint a...
BIXT - Bioxytran Announces Government Interest After Initial BARDA Techwatch Light Meeting

BOSTON, MASSACHUSETTS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced a well-attende...

Previous 10 Next 10